Depression Archives

Medicine

Gepirone Under Review for Major Depressive Disorder

By

Steve Duffy

January 27, 2023

Exxua (previously named Travivo) is a novel oral serotonin 1A receptor agonist.

Medicine

IV Ketamine in Treatment-Resistant Bipolar Depression Shows Real-World Efficacy

By

Ron Goldberg

January 25, 2023

Researchers sought to characterize real-world efficacy of repeated ketamine infusions for treatment-resistant bipolar depression assessing symptoms of depression, anxiety, suicidality, and functioning.

Medicine

Life Stressors Exacerbate Long COVID Symptoms in Patients Following Hospitalization

By

Jessica Nye, PhD

January 18, 2023

In a prospective, longitudinal study, researchers assessed the effect of demographics, pre-COVID-19 comorbidities, index COVID-19 hospitalization metrics, and life stressors on 6- and 12-month outcome metrics in adult patients post-COVID-19 hospitalization.

Medicine

Complicated Appendicitis More Likely Among Patients With Psychiatric Disorders

By

Jessica Nye, PhD

January 17, 2023

Patients with acute appendicitis between 2000 and 2020 were evaluated for complications on the basis of having a mental health diagnosis.

Medicine

Lifestyle Modification Program Had Similar Outcomes as Mindfulness, Placebo in Treatment-Resistant Depression

By

Jessica Nye, PhD

January 11, 2023

A pragmatic, parallel-group, randomized control trial was conducted between 2020 and 2021 to ascertain whether a lifestyle modification program had an effect on patients with treatment-resistance depression.

Medicine

5-ARIs Linked With Depression, But Not Suicide Risk

By

Natasha Persaud

January 10, 2023

This Swedish population-based study has the largest sample size to date exploring these associations.

Pediatrics

Interventions Targeting Repetitive Negative Thinking May Improve Depression, Anxiety

By

Jessica Nye, PhD

December 29, 2022

Can reducing RNT with psychological treatment approaches help improve youth depression and anxiety?

Medicine

Vraylar Approved as Adjunctive Therapy for Major Depressive Disorder

By

Diana Ernst, RPh

December 19, 2022

The approval was based on data from 2 trials in adults who met DSM-IV-TR or DSM-5 criteria for MDD and had an inadequate response to 1 to 3 courses of prior antidepressant therapy.